C
China Regenerative Medicine International Ltd
HKEX:8592
China Regenerative Medicine International Ltd
HKEX:8592
Price:
0.98
HKD
Market Closed
Market Cap:
HK$279.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
C
|
China Regenerative Medicine International Ltd
HKEX:8592
|
HK |
|
G
|
Gamsung Corporation Co Ltd
KOSDAQ:036620
|
KR |
|
S
|
Sincere Watch (Hong Kong) Ltd
HKEX:444
|
HK |
|
Emperor Watch & Jewellery Ltd
HKEX:887
|
HK |
|
Tern PLC
LSE:TERN
|
UK |
|
PCI Biotech Holding ASA
OSE:PCIB
|
NO |
|
Shanghai Pudong Development Bank Co Ltd
SSE:600000
|
CN |
|
Hampton Financial Corp
XTSX:HFC
|
CA |
Multiples-Based Value
The Multiples-Based Value of one China Regenerative Medicine International Ltd stock under the Base Case scenario is hidden HKD. Compared to the current market price of 0.98 HKD, China Regenerative Medicine International Ltd is hidden .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
China Regenerative Medicine International Ltd Multiples-Based Value
LOCKED
Multiples Across Competitors
Competitors Multiples
China Regenerative Medicine International Ltd Competitors
China Regenerative Medicine International Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| HK |
C
|
China Regenerative Medicine International Ltd
HKEX:8592
|
92.8m HKD | 1.6 | 16.8 | 91.3 | 91.3 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
370.2B USD | 6.1 | 88.4 | 14.7 | 20.4 | |
| US |
|
Exact Sciences Corp
NASDAQ:EXAS
|
355.4B USD | 109.4 | -1 708.3 | 15 870 | -1 791.9 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
188B USD | 5.1 | 24.4 | 14.1 | 14.1 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
166.6B USD | 5.7 | 19.6 | 12.3 | 15.1 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
110B USD | 9.2 | 27.8 | 20.9 | 21.8 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
78B USD | 5.4 | 17.3 | 12.7 | 14.5 | |
| AU |
|
CSL Ltd
ASX:CSL
|
69B AUD | 3.2 | 35.1 | 11.5 | 14.5 | |
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR | 20.1 | -61.8 | -66.6 | -60.1 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
